Shareholding disclosure

AXA S.A

Declared position

3.28%

Threshold

Crossed upwards

Timeline

Published

22.06.2019

Transaction

19.11.2018

Voting rights breakdown

Voting rights acquired3.28%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ6L00049

Beneficial owner

AXA S.A

Declared address

AXA S.A., Paris

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

AXA S.A

Newron Pharmaceuticals S.p.A.22.06.2019TAJ6L00049

Disclosure summary

AXA S.A disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 22.06.2019, at 3.28% of voting rights. Notice category: Single shareholder.

Disclosed position

3.28%

Voting rights acquired

Voting rights acquired3.28%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

AXA S.A disclosed a holding in Newron Pharmaceuticals S.p.A., published on 22.06.2019.

Publication date22.06.2019

Transaction date19.11.2018

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerAXA S.A

Declared addressAXA S.A., Paris

CategorySingle shareholder

Voting rights acquired3.28%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAJ6L00049

Source: SIX Exchange Regulation · Publication date: 22.06.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open